State Licensing GuideHawaii

Hawaii Wholesale Drug Distributor License Guide

Comprehensive guide to Hawaii wholesale drug distributor licensing requirements. Covers application procedures, designated representative qualifications, out-of-state requirements, renewal processes, and compliance data for 59 tracked entities operating in Hawaii.

Hawaii Wholesale Drug Distributor Licensing: Foundation Guide

Overview

Wholesale drug distributors operating in Hawaii — whether resident or non-resident — must obtain a license from the Hawaii State Board of Pharmacy before engaging in wholesale distribution of prescription drugs into or within the state. Hawaii requires both physical facilities located in-state and out-of-state distributors shipping into Hawaii to hold valid licensure. The state's regulatory framework is established under Hawaii Revised Statutes Chapter 461 and enforced through administrative rules in Hawaii Administrative Rules Title 16, Chapter 95.

Regulatory Authority

The Hawaii State Board of Pharmacy (HSBP) administers wholesale drug distributor licensing under the authority of Hawaii Revised Statutes (HRS) Chapter 461 (Pharmacy Practice Act) and Hawaii Administrative Rules (HAR) Title 16, Chapter 95. Specific wholesale distributor licensing requirements are codified in HRS §461-11 and HAR §16-95-70 through §16-95-76.

The Board operates under the Department of Commerce and Consumer Affairs, Professional and Vocational Licensing Division:

  • Mailing Address: P.O. Box 3469, Honolulu, HI 96801
  • Phone: (808) 586-2694
  • Website: https://cca.hawaii.gov/pvl/boards/pharmacy/

Who Must Be Licensed

Hawaii requires wholesale drug distributor licenses for the following entity types:

  • Resident wholesalers — Any entity with a physical location in Hawaii engaged in wholesale distribution of prescription drugs
  • Non-resident wholesalers — Out-of-state entities that distribute, ship, mail, or deliver prescription drugs into Hawaii, regardless of physical presence in the state
  • Third-party logistics providers (3PLs) — Entities providing warehousing or logistics services for prescription drugs on behalf of others
  • Repackagers — Entities that repackage prescription drugs for further distribution
  • Virtual distributors — Entities engaged in wholesale distribution without physical handling of drugs (brokering, trading activities)

Exemptions (subject to specific conditions):

  • Manufacturers distributing their own FDA-approved products
  • Licensed pharmacies distributing to other pharmacies or practitioners in limited quantities (typically not exceeding 5% of gross sales)
  • Licensed practitioners administering or dispensing drugs in professional practice
  • Common carriers acting solely as shipping agents
  • Federal facilities and agencies (VA, DoD)
  • Charitable distribution programs meeting specific statutory requirements

Exemption qualifications should be verified directly with the Hawaii Board of Pharmacy as they carry specific limitations and conditions.

Application Requirements

A complete wholesale drug distributor license application must include:

Business Entity Documentation:

  • Legal business name, trade names/DBAs, and federal tax ID number
  • Business structure documentation (articles of incorporation, partnership agreement, LLC formation documents)
  • Physical address of all facilities (no P.O. boxes)
  • Contact information (phone, fax, email)

Ownership and Management Information:

  • Names, addresses, and dates of birth for all owners, officers, directors, and partners
  • Organizational chart showing management structure
  • Information on parent companies or affiliated entities

Designated Representative Requirements:

  • Identification of at least one designated representative
  • Proof of designated representative qualifications (minimum 2 years verifiable experience in wholesale distribution or equivalent education/experience combination)
  • Demonstration of knowledge in federal/state laws, drug storage/handling, pedigree documentation, and recall procedures
  • Criminal background check results
  • Employment verification

Facility Information:

  • Detailed facility description including square footage, storage conditions, security measures
  • Evidence of adequate storage capacity and environmental controls
  • Security system documentation

Licensure Documentation:

  • Current state wholesale drug distributor license from state of domicile (for out-of-state applicants)
  • Current DEA registration certificate (if handling controlled substances)
  • FDA registration documentation
  • Current NABP VAWD accreditation (if applicable)

Financial Documentation:

  • Surety bond issued by a company authorized to do business in Hawaii (verify current required amount with Board)

Operational Documentation:

  • Written policies and procedures for wholesale distribution operations
  • Standard operating procedures for storage, handling, recall procedures, and record-keeping
  • Quality assurance and quality control procedures

Additional Requirements:

  • List of prescription drug categories to be distributed
  • List of states where applicant holds wholesale distributor licenses
  • Certification of compliance with federal and state laws
  • Completed application form with authorized signature
  • Required application fee

Application Process

  1. Pre-Application Preparation — Gather all required documentation, obtain surety bond, ensure designated representative meets qualifications
  1. Account Creation — Create an account in the Hawaii Compliance Express (HCE) online portal at https://hce.ehawaii.gov/
  1. Application Completion — Complete the wholesale drug distributor application form with all required business and personnel information
  1. Document Submission — Submit all supporting documentation including licenses, bonds, policies, and facility information through the online portal or by mail as required
  1. Fee Payment — Pay the required application fee through the online system or by check if mailing
  1. Application Review — Board staff reviews application for completeness and compliance with statutory requirements
  1. Facility Inspection — Board may schedule and conduct a pre-licensing inspection. Required for resident wholesalers; out-of-state facilities may be inspected or may rely on home-state inspection
  1. Deficiency Notification — If application is incomplete, Board notifies applicant of additional requirements
  1. Board Approval — Complete applications are reviewed and approved by the Board or designated staff
  1. License Issuance — Upon approval, license is issued electronically or by mail

Processing Time: Typical timeframe is 60-90 days for complete applications. Processing may be longer if inspection is required or during high-volume periods. Expedited processing is generally not available. Verify current processing times with the Board as they fluctuate based on staffing and application volume.

Out-of-State Requirements

Non-resident wholesale drug distributors shipping prescription drugs into Hawaii must comply with the following specific requirements:

Licensure: Must obtain a Hawaii wholesale drug distributor license regardless of physical presence in the state.

Home-State License: Must maintain a valid wholesale drug distributor license in good standing in the state where the facility is located.

Application: Must submit the same application and documentation as resident wholesalers, including:

  • Copy of current wholesale distributor license from home state
  • Copy of current DEA registration
  • Designated representative information meeting Hawaii qualifications
  • Surety bond valid for Hawaii jurisdiction
  • All ownership and facility documentation

Inspection:

  • Hawaii Board may conduct inspections of out-of-state facilities
  • Hawaii may accept inspection reports from the home state where reciprocity agreements exist
  • Board may require third-party inspection reports or VAWD accreditation in lieu of direct inspection
  • Verify current inspection policy with the Board

Agent for Service: Out-of-state wholesalers may be required to designate an agent in Hawaii for service of process.

Reporting Obligations:

  • Notify Hawaii Board of any changes in ownership, location, or designated representative
  • Report any disciplinary actions in other states
  • Report any license suspensions or revocations in other jurisdictions
  • Maintain records accessible to Hawaii Board inspectors

Fees

License TypeInitial Application FeeRenewal Fee
Wholesale Drug Distributor (Resident)Verify with BoardVerify with Board
Wholesale Drug Distributor (Non-Resident)Verify with BoardVerify with Board

Additional Fees:

  • Late Renewal Penalty: Verify with Board (typically 1.5x regular renewal fee)
  • Reinstatement Fee: Verify with Board (higher than renewal fee)
  • Duplicate License Fee: Verify with Board

Payment Methods:

  • Online payments through Hawaii Compliance Express (credit/debit card with processing fee)
  • Check or money order payable to "Department of Commerce and Consumer Affairs"

All fees should be verified directly with the Hawaii Board of Pharmacy at (808) 586-2694 before submitting an application, as fee schedules are subject to change through administrative rulemaking.

Renewal Requirements

Renewal Cycle: Wholesale drug distributor licenses in Hawaii expire biennially (every two years). Renewal period dates should be verified with the Board. Licensees receive renewal notices approximately 60 days before expiration.

Renewal Process:

Renewals are completed through the Hawaii Compliance Express (HCE) online portal at https://hce.ehawaii.gov/. Licensees must submit:

  • Completed renewal application with updated business information
  • Confirmation of continued compliance with all licensing requirements
  • Updated designated representative information (if changed)
  • Current surety bond documentation
  • Current home-state license (for non-resident wholesalers)
  • Current DEA registration
  • Attestation of no material changes or disclosure of any changes in ownership, location, or operations
  • Disclosure of any disciplinary actions in other jurisdictions
  • Payment of biennial renewal fee

The Board may conduct renewal inspections on a scheduled or random basis.

Grace Period: Verify with the Board whether Hawaii provides a grace period for renewal. If a grace period exists, it is typically 30-60 days with a late penalty. Operating on an expired license may be prohibited even during a grace period.

Penalties for Expired License:

  • Late Renewal: Financial penalty assessed for renewals submitted after expiration (verify specific amount with Board)
  • Operating Without Valid License: Operating as a wholesale distributor with an expired license constitutes a violation of Hawaii pharmacy law and may result in administrative penalties, disciplinary action, and in serious cases, criminal charges
  • Transaction Invalidation: Wholesale distribution conducted during unlicensed periods may be invalidated
  • Reinstatement: Licenses that lapse beyond any grace period may require a reinstatement application with higher fees and additional documentation rather than simple renewal

Continuing Requirements: At renewal, licensees must demonstrate maintained compliance with all operational requirements, no unresolved disciplinary actions, continued financial responsibility (surety bond), and that the designated representative remains qualified and employed.

Licensees must cease wholesale distribution activities immediately upon license expiration if not renewed.

ColdChainCheck Data Snapshot

Hawaii's wholesale drug distributor landscape shows moderate compliance performance with significant license maintenance challenges. The state tracks 59 entities with an average compliance score of 59/100 and a median of 60/100, placing most distributors in the "Fair" compliance tier. Notably, only 54% of licenses in the state are active — 38 of 70 total licenses — with 32 expired licenses representing a substantial proportion of inactive credentials. This 54% active rate is below the national average and suggests either high business turnover or inadequate license maintenance among Hawaii-based entities. On the positive side, 12 entities hold NABP accreditation (20% of tracked entities), indicating a core group of distributors maintaining higher compliance standards. All 59 tracked entities are FDA-registered, reflecting baseline federal compliance across the population.

MetricHawaii
Tracked entities59
Average compliance score59/100
Median compliance score60/100
Active licenses38
Expired licenses32
Active license rate (%)54%
NABP-accredited entities12
FDA-registered entities59

Top Entities in Hawaii

The following entities demonstrate the strongest compliance posture in Hawaii based on verified licensure, accreditation status, and regulatory history:

  1. JOM Pharmaceutical Services LLC — 90/100
  2. Henry Schein — 88/100
  3. ASD Healthcare — 85/100
  4. Cencora — 85/100
  5. FISHER BIOSERVICES INC. — 85/100

These scores reflect multi-state licensing breadth, NABP accreditation where applicable, FDA registration status, and clean regulatory records across tracked enforcement actions. Scores are calculated using ColdChainCheck's standardized methodology.

Related Entities

The complete list of wholesale drug distributors operating in or shipping into Hawaii is available in the ColdChainCheck directory. The directory includes all 59 tracked entities with detailed compliance profiles, license status, accreditation information, and enforcement history. Directory data is updated periodically as new license information is ingested from the Hawaii State Board of Pharmacy and federal databases.

Disclaimer

This guide is provided for informational purposes only and does not constitute legal or regulatory advice. Wholesale drug distributor licensing requirements are subject to change through legislative or administrative action. Applicants should verify all requirements, fees, forms, and procedures directly with the Hawaii State Board of Pharmacy before submitting an application or making business decisions based on this content. ColdChainCheck is an independent compliance data directory and is not affiliated with any state regulatory authority.

Disclaimer: This guide is for informational purposes only and does not constitute legal or regulatory advice. Licensing requirements change frequently. Always verify current requirements with the relevant state board of pharmacy or regulatory authority before making compliance decisions.